Proportion of children who received the vaccine under study (OPV3) · children under 5 years of age
It is very uncertain whether home visit changes proportion of children who received the vaccine under study (OPV3) compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (measles) · children under 5 years of age
It is very uncertain whether home visit changes proportion of children who received the vaccine under study (measles) compared with routine care (very low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (BCG) · children under 5 years of age
It is very uncertain whether immunisation outreach changes proportion of children who received the vaccine under study (BCG) compared with routine care (very low certainty).
1 finding from 1 review
Received at least one vaccine · children under 5 years of age
Health education probably leads to higher received at least one vaccine compared with routine care (moderate certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (HBV3) · children under 5 years of age
It is very uncertain whether immunisation outreach changes proportion of children who received the vaccine under study (HBV3) compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (OPV3) · children under 5 years of age
It is very uncertain whether immunisation outreach changes proportion of children who received the vaccine under study (OPV3) compared with routine care (very low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (measles) · children under 5 years of age
It is very uncertain whether immunisation outreach changes proportion of children who received measles vaccine compared with routine care (very low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (BCG) · children under 5 years of age
Integration of immunisation with other health services showed no clear difference in proportion of children who received the vaccine under study (BCG) compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (yellow fever) · children under 5 years of age
Integration of immunisation with other health services may leads to higher proportion of children who received the vaccine under study (yellow… compared with routine care (low certainty).
1 finding from 1 review
Proportion of children who received the vaccine under study (measles) · children under 5 years of age
Integration of immunisation with other health services may leads to higher proportion of children who received the vaccine under study (measles) compared with routine care (low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Relapse Defined as MUAC < 115 mm within 2 months after recovery (Hussain 2021) · children aged > 6 months and ≤ 5 years with wasting
The intervention showed no clear difference in relapse Defined as MUAC < 115 mm within 2 months after recovery… (moderate certainty).
1 finding from 1 review